» Authors » Anna-Laura Potthoff

Anna-Laura Potthoff

Explore the profile of Anna-Laura Potthoff including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 55
Citations 495
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Schneider M, Potthoff A, Ahmadipour Y, Borger V, Clusmann H, Combs S, et al.
BMC Cancer . 2025 Feb; 25(1):306. PMID: 39979825
Background: The discovery of cellular tumor networks in glioblastoma, with routes of malignant communication extending far beyond the detectable tumor margins, has highlighted the potential of supramarginal resection strategies. Retrospective...
2.
Zeyen T, Weller J, Schneider M, Potthoff A, Schaub C, Roever L, et al.
Neurooncol Adv . 2025 Feb; 7(1):vdaf005. PMID: 39902392
Background: Polychemotherapy based on high-dose methotrexate (HD-MTX) is the standard therapy for newly diagnosed younger patients (<65 years) with primary CNS lymphoma (PCNSL). In the modified Bonn protocol, consolidation therapy...
3.
Schmidt E, Evert B, Pregler B, Melhem A, Hsieh M, Raspe M, et al.
Mol Oncol . 2024 Dec; 19(3):878-898. PMID: 39680504
Glioblastoma cells rely on connexin 43 (Cx43)-based gap junctions (GJs) for intercellular communication, enabling them to integrate into a widely branched malignant network. Although there are promising prospects for new...
4.
Shabo E, Potthoff A, Zeyen T, Layer J, Ehrentraut S, Scorzin J, et al.
J Neurooncol . 2024 Nov; 171(3):681-689. PMID: 39607570
Purpose: Prophylactic insertion of an external ventricular drainage (EVD) prior to the resection of posterior fossa metastases (PFMs) is a common approach to address postoperative transient and permanent hydrocephalus. However,...
5.
Weller J, Kocakavuk E, Pregler B, Zeyen T, Schafer N, Potthoff A, et al.
Neuro Oncol . 2024 Nov; 27(1):306-308. PMID: 39545540
No abstract available.
6.
Gessler F, Hajdari S, Potthoff A, Bernstock J, Herrlinger U, Czabanka M, et al.
J Neurosurg . 2024 Oct; 142(3):722-730. PMID: 39393103
Objective: Visual acuity (VA) constitutes an important outcome measure in surgery for medial sphenoid wing meningioma (SWM). This study aimed to assess the recovery of tumor-associated impairment of VA and...
7.
Zeyen T, Bohm L, Paech D, Schafer N, Tzaridis T, Duffy C, et al.
Neuro Oncol . 2024 Oct; 27(2):557-566. PMID: 39351820
Background: Maximum tumor resection improves overall survival (OS) in patients with glioblastoma. The extent of resection (EOR) is historically dichotomized. The response assessment in neuro-oncology (RANO) resects group recently proposed...
8.
Lizunou Y, Potthoff A, Schafer N, Waha A, Borger V, Herrlinger U, et al.
J Cancer Res Clin Oncol . 2024 Sep; 150(9):432. PMID: 39340649
Purpose: The rarity of cerebellar glioblastoma presents a significant challenge in clinical practice due to the lack of extensive prognostic data on long-term survival rates, rendering it an underrepresented entity...
9.
Zeyen T, Friker L, Paech D, Schaefer N, Weller J, Zschernack V, et al.
J Cancer Res Clin Oncol . 2024 Sep; 150(9):437. PMID: 39340558
Purpose: Little is known about the effect of SARS-CoV-2 infection on glioblastoma (GBM) growth, metabolism, and prognosis. Immunological changes within GBM tissue are potentially symptomatic, underlining the urgent need for...
10.
Weller J, Potthoff A, Zeyen T, Schaub C, Duffy C, Schneider M, et al.
Mol Oncol . 2024 Jun; 18(12):2927-2950. PMID: 38899374
The concept of precision oncology, the application of targeted drugs based on comprehensive molecular profiling, has revolutionized treatment strategies in oncology. This review summarizes the current status of precision oncology...